Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1131-1137

  Haioun, C ^a   Lepage, E ^a   Gisselbrecht, C ^a   Bastion, Y ^a   Coiffier, B ^a   Brice, P ^a   Bosly, A ^a   Dupriez, B ^a   Nouvel, C ^a   Tilly, H ^a   Lederlin, P ^a   Biron, P ^a   Briere J ^a   Gaulard, P ^a   Reyes, F ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINDESINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HIGH RISK POPULATION; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031056945     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1131     Document Type: Article

References (23)

1. Philip T, Armitage JO, Spitzer G, et al: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermdiate-grade or high-grade non Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
2. Armitage JO: Bone marrow transplantation in the treatment of patients with lymphoma. Blood 73:1749-1758, 1989
3. Cabanillas F, Jagannath S, Philip T: Management of recurrent or refractory disease, in Magrath I (ed): The Non-Hodgkin's Lymphoma. London, United Kingdom, Edward Arnold, 1990, pp 359-372
4. Freedman AS, Takvorian T, Anderson KC, et al: Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: Very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784-791, 1990
5. Bosly A, Coiffier B, Gisselbrecht C: Bone marrow transplantation prolongs survival after relapse in aggressive lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 10:1615-1623, 1992
6. Peterson BA: The role of transplantation in non Hodgkin's lymphoma. J Clin Oncol 12:2524-2526, 1994 (editorial)
7. Vose JM: Treatment for non-Hodgkin's lymphoma in relapse. N Engl J Med 333:1565-1566, 1995 (editorial)
8. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
9. Gulati SC, Shank B, Black P, et al: Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 6:1303-1313, 1988
10. Nademanee A, Schmidt GM, O'Donnel MR, et al: High-dose chemotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: A pilot study. Blood 80:1130-1134, 1992
11. Freedman AS, Takvorian T, Neuberg D, et al: Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: A pilot study. J Clin Oncol 11:931-936, 1993
12. Sierra J, Conde E, Montserrat E: Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission. Blood 81:1968, 1993 (letter)
13. Haioun C, Lepage E, Gisselbrecht C, et al: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 12:2543-2551, 1994
14. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
15. The International Non Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
16. Coiffier B, Gisselbrecht C, Herbrecht R, et al: LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018-1026, 1989
17. Kaplan EL, Meier P: Nonparametic estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
19. Gail M, Simon R: Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 41:361-372, 1985
20. Shipp MA, Harrington DP, Klatt MM, et al: Identification of major prognostic subgroups of patient with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med 104:757-765, 1986
21. Verdonck LF, Van Putten WLJ, Hagenbeek A, et al: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332:1045-1051, 1995
22. Martelli M, Vignetti M, Zinzani PL, et al: High-dose therapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study. J Clin Oncol 12:534-542, 1996
23. Pettengel R, Radford JA, Morgenstern GR, et al: Survival benefit from high-dose therapy with autologous blood progenitor cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 14:586-592, 1996